ad image

Risk Assessment

1 / 1
Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare
New CDMO Facility

Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare

Grifols

PAO-02-23-PATV-04Feb 23, 2023
CAPA Management is Worth Doing, and Worth Doing Well
CAPA Management

CAPA Management is Worth Doing, and Worth Doing Well

Helen Lowe

PAO-04-022-CL-11May 04, 2022
U.S. Food & Drug Administration
Regulatory

FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review

U.S. Food & Drug Administration

PR-M03-22-03Mar 07, 2022
Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations
Nitrosamine

Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations

Ulrich Reichert, M.D.R.A.

MilliporeSigma

PAO-02021-CL-05Feb 10, 2021
Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?
Roundtable

Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?

Pharma's Almanac

PAP-Q4-20-NI-007Dec 09, 2020
Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach
Equipment

Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach

CRB USA

PAP-Q2-17-CL-010Jun 05, 2017
Keeping it Clean

Keeping it Clean

Nice Insight

PTV-M11-16-AP-005Apr 06, 2017
1 / 1